Market Cap 4.66B
Revenue (ttm) 703.24M
Net Income (ttm) 126.71M
EPS (ttm) N/A
PE Ratio 12.67
Forward PE 12.96
Profit Margin 18.02%
Debt to Equity Ratio 0.92
Volume 2,372,700
Avg Vol 2,870,728
Day's Range N/A - N/A
Shares Out 249.35M
Stochastic %K 62%
Beta 0.84
Analysts Sell
Price Target $21.08

Company Profile

As of June 30, 2025, Sabra's investment portfolio included 359 real estate properties held for investment (consisting of (i) 219 skilled nursing/transitional care facilities, (ii) 36 senior housing communities (“senior housing - leased”), (iii) 73 senior housing communities operated by third-party property managers pursuant to property management agreements (“senior housing - managed”), (iv) 16 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 13 investments in l...

Industry: REIT - Healthcare Facilities
Sector: Real Estate
Phone: 888 393 8248
Fax: 949 679 8868
Address:
1781 Flight Way, Tustin, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:06 AM
$SBRA: The last close at $18.68 indicates a position above the 30-day moving average (MA30) of $18.12 and the 50-day moving average (MA50) of $18.39, suggesting bullish momentum. The RSI at 57.94 indicates that the stock is neither overbought nor oversold, allowing for potential upside without immediate risk of reversal. The recent 60-day high of $19.97 provides a target that is within reach, while the 60-day low of $17.17 establishes a solid support level. Trade Plan: - Suggested Entry: $18.70 (slightly above last close to confirm upward momentum) - Stop: $18.10 (below MA30 for risk management) - Target 1: $19.00 (psychological level) - Target 2: $19.50 (near the 60D high) Overall, the market context shows a bullish bias with favorable technical indicators supporting upward movement. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:39 AM
$SBRA: The last close at $18.68 indicates a position above the 30-day moving average (MA30) of $18.12 and the 50-day moving average (MA50) of $18.39, suggesting bullish momentum. The RSI at 57.94 indicates that the stock is neither overbought nor oversold, allowing for potential upside without immediate risk of reversal. The recent 60-day high of $19.97 provides a target that is within reach, while the 60-day low of $17.17 establishes a solid support level. Trade Plan: - Suggested Entry: $18.70 (slightly above last close to confirm upward momentum) - Stop: $18.10 (below MA30 for risk management) - Target 1: $19.00 (psychological level) - Target 2: $19.50 (near the 60D high) Overall, the market context shows a bullish bias with favorable technical indicators supporting upward movement. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:45 AM
$SBRA: The last close at $19.16 indicates a bullish sentiment, supported by an RSI of 63.11, which suggests the stock is nearing overbought territory but still has room for upward movement. The 30-day moving average (MA30) at $18.09 and the 50-day moving average (MA50) at $18.40 indicate a strong upward trend, as the current price is well above both averages. The 60-day high of $19.97 presents a resistance level, while the 60-day low of $17.17 provides a solid support base. Directional bias is bullish, as the price is above key moving averages and within striking distance of the recent high. Suggested entry is around $19.00 to capitalize on potential upward momentum. Set a stop-loss at $18.50 to manage risk. Target 1 is $19.50, just below the 60D high, and Target 2 is $20.00, a psychological level that may attract buyers. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:21 AM
$SBRA: The last close at $19.16 indicates a bullish sentiment, supported by an RSI of 63.11, which suggests the stock is nearing overbought territory but still has room for upward movement. The 30-day moving average (MA30) at $18.09 and the 50-day moving average (MA50) at $18.40 indicate a strong upward trend, as the current price is well above both averages. The 60-day high of $19.97 presents a resistance level, while the 60-day low of $17.17 provides a solid support base. Directional bias is bullish, as the price is above key moving averages and within striking distance of the recent high. Suggested entry is around $19.00 to capitalize on potential upward momentum. Set a stop-loss at $18.50 to manage risk. Target 1 is $19.50, just below the 60D high, and Target 2 is $20.00, a psychological level that may attract buyers. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Winning_calls
Winning_calls Nov. 10 at 4:04 AM
$SBRA pick me up @ $18.95
0 · Reply
CashFlowRatio
CashFlowRatio Nov. 8 at 9:00 AM
$SBRA how many analysts said this goes to $20? Was it 7?
0 · Reply
Demacrap
Demacrap Nov. 5 at 9:26 PM
$SBRA but to cover a few sheckles down here
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 31 at 5:33 PM
$SBRA you know what else is doable? SBRA going straight up just like it currently is doing!
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 28 at 5:31 PM
$SBRA tomorrow there should be an interest rate cut. Earnings is out soon.
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 24 at 8:13 AM
$SBRA well look at that moving up nicely!
0 · Reply
Latest News on SBRA
Sabra Health Care: SHOP Model As A Value Catalyst

Oct 11, 2025, 3:43 AM EDT - 4 weeks ago

Sabra Health Care: SHOP Model As A Value Catalyst


Sabra Health Care: Buy This High Yield While It's Undervalued

Sep 25, 2025, 10:01 AM EDT - 7 weeks ago

Sabra Health Care: Buy This High Yield While It's Undervalued


Sabra Health Care REIT, Inc. to Attend Fall Conferences

Sep 5, 2025, 4:46 PM EDT - 2 months ago

Sabra Health Care REIT, Inc. to Attend Fall Conferences


Sabra Publishes Fifth Annual Sustainability Report

Jul 30, 2025, 4:05 PM EDT - 3 months ago

Sabra Publishes Fifth Annual Sustainability Report

ESG


Sabra Health: Steady Earnings, But Not Yet Fully Mature

Jul 16, 2025, 9:07 AM EDT - 4 months ago

Sabra Health: Steady Earnings, But Not Yet Fully Mature


Sabra Health Care REIT: High Dividend And Growth Potential

Jul 10, 2025, 8:00 AM EDT - 4 months ago

Sabra Health Care REIT: High Dividend And Growth Potential


Sabra Health Care REIT: Come For Income, Stay For Growth

Mar 19, 2025, 2:41 PM EDT - 8 months ago

Sabra Health Care REIT: Come For Income, Stay For Growth


Sabra Health Care REIT, Inc. Announces Leadership Promotions

Feb 17, 2025, 4:05 PM EST - 9 months ago

Sabra Health Care REIT, Inc. Announces Leadership Promotions


Final Trades: Amazon, Sabra Health Care and the IEO

Dec 27, 2024, 1:55 PM EST - 11 months ago

Final Trades: Amazon, Sabra Health Care and the IEO

AMZN IEO


Sabra Health Care REIT: Turning The Corner

Sep 20, 2024, 9:00 AM EDT - 1 year ago

Sabra Health Care REIT: Turning The Corner


10 Sweet REITs: Yield Up To 6.6%

Sep 18, 2024, 5:10 PM EDT - 1 year ago

10 Sweet REITs: Yield Up To 6.6%

DLR IRM MPW NNN O OHI SPG


Sabra Publishes Fourth Annual Sustainability Report

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Sabra Publishes Fourth Annual Sustainability Report


PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:06 AM
$SBRA: The last close at $18.68 indicates a position above the 30-day moving average (MA30) of $18.12 and the 50-day moving average (MA50) of $18.39, suggesting bullish momentum. The RSI at 57.94 indicates that the stock is neither overbought nor oversold, allowing for potential upside without immediate risk of reversal. The recent 60-day high of $19.97 provides a target that is within reach, while the 60-day low of $17.17 establishes a solid support level. Trade Plan: - Suggested Entry: $18.70 (slightly above last close to confirm upward momentum) - Stop: $18.10 (below MA30 for risk management) - Target 1: $19.00 (psychological level) - Target 2: $19.50 (near the 60D high) Overall, the market context shows a bullish bias with favorable technical indicators supporting upward movement. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:39 AM
$SBRA: The last close at $18.68 indicates a position above the 30-day moving average (MA30) of $18.12 and the 50-day moving average (MA50) of $18.39, suggesting bullish momentum. The RSI at 57.94 indicates that the stock is neither overbought nor oversold, allowing for potential upside without immediate risk of reversal. The recent 60-day high of $19.97 provides a target that is within reach, while the 60-day low of $17.17 establishes a solid support level. Trade Plan: - Suggested Entry: $18.70 (slightly above last close to confirm upward momentum) - Stop: $18.10 (below MA30 for risk management) - Target 1: $19.00 (psychological level) - Target 2: $19.50 (near the 60D high) Overall, the market context shows a bullish bias with favorable technical indicators supporting upward movement. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:45 AM
$SBRA: The last close at $19.16 indicates a bullish sentiment, supported by an RSI of 63.11, which suggests the stock is nearing overbought territory but still has room for upward movement. The 30-day moving average (MA30) at $18.09 and the 50-day moving average (MA50) at $18.40 indicate a strong upward trend, as the current price is well above both averages. The 60-day high of $19.97 presents a resistance level, while the 60-day low of $17.17 provides a solid support base. Directional bias is bullish, as the price is above key moving averages and within striking distance of the recent high. Suggested entry is around $19.00 to capitalize on potential upward momentum. Set a stop-loss at $18.50 to manage risk. Target 1 is $19.50, just below the 60D high, and Target 2 is $20.00, a psychological level that may attract buyers. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:21 AM
$SBRA: The last close at $19.16 indicates a bullish sentiment, supported by an RSI of 63.11, which suggests the stock is nearing overbought territory but still has room for upward movement. The 30-day moving average (MA30) at $18.09 and the 50-day moving average (MA50) at $18.40 indicate a strong upward trend, as the current price is well above both averages. The 60-day high of $19.97 presents a resistance level, while the 60-day low of $17.17 provides a solid support base. Directional bias is bullish, as the price is above key moving averages and within striking distance of the recent high. Suggested entry is around $19.00 to capitalize on potential upward momentum. Set a stop-loss at $18.50 to manage risk. Target 1 is $19.50, just below the 60D high, and Target 2 is $20.00, a psychological level that may attract buyers. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Winning_calls
Winning_calls Nov. 10 at 4:04 AM
$SBRA pick me up @ $18.95
0 · Reply
CashFlowRatio
CashFlowRatio Nov. 8 at 9:00 AM
$SBRA how many analysts said this goes to $20? Was it 7?
0 · Reply
Demacrap
Demacrap Nov. 5 at 9:26 PM
$SBRA but to cover a few sheckles down here
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 31 at 5:33 PM
$SBRA you know what else is doable? SBRA going straight up just like it currently is doing!
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 28 at 5:31 PM
$SBRA tomorrow there should be an interest rate cut. Earnings is out soon.
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 24 at 8:13 AM
$SBRA well look at that moving up nicely!
0 · Reply
JarvisFlow
JarvisFlow Oct. 21 at 1:18 PM
Wells Fargo has updated their rating for Sabra Health Care REIT ( $SBRA ) to Overweight with a price target of 20.
0 · Reply
CashFlowRatio
CashFlowRatio Oct. 7 at 6:32 PM
$SBRA moving up today.
0 · Reply
Demacrap
Demacrap Oct. 3 at 6:45 PM
$SBRA a short to 16 is doable
0 · Reply
JarvisFlow
JarvisFlow Oct. 1 at 1:58 PM
Cantor Fitzgerald has updated their rating for Sabra Health Care REIT ( $SBRA ) to Neutral with a price target of 20.
0 · Reply
CashFlowRatio
CashFlowRatio Sep. 22 at 6:43 PM
$SBRA Fair value price $38.39 Way below that! Check the intrinsic value yourself.
0 · Reply
fishouttawater12
fishouttawater12 Sep. 16 at 3:00 AM
$SBRA up after hours 👀
0 · Reply
CashFlowRatio
CashFlowRatio Sep. 10 at 6:19 PM
$SBRA Moody’s upgraded SBRA to investment grade.
0 · Reply
CashFlowRatio
CashFlowRatio Sep. 10 at 6:15 PM
$SBRA will the Fed cut rates next week?
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 4:16 PM
$SBRA Great piece that accurately captures SBRA's current position. So if you want to refresh your understanding of SBRA or learn about SBRA for the first time, this is essential reading. https://beyondspx.com/quote/SBRA/analysis/sabra-health-care-reit-fortifying-growth-through-disciplined-shop-expansion-and-operational-tech-nasdaq-sbra
0 · Reply
CashFlowRatio
CashFlowRatio Sep. 7 at 11:38 PM
$SBRA I saw the ask at $20 for a while during trading hours.
0 · Reply
JarvisFlow
JarvisFlow Sep. 3 at 1:00 PM
Truist Securities has adjusted their stance on Sabra Health Care REIT ( $SBRA ), setting the rating to Hold with a target price of 18 → 20.
0 · Reply
JarvisFlow
JarvisFlow Aug. 27 at 2:04 PM
Wells Fargo updates rating for Sabra Health Care REIT ( $SBRA ) to Overweight, target set at 20 → 21.
0 · Reply